LIPROTEK- petrolatum, lidocaine ointment

Liprotek by

Drug Labeling and Warnings

Liprotek by is a Otc medication manufactured, distributed, or labeled by Unit Dose, Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Uses:

TEMPORARY RELIEF OF PAIN and/or ITCHING FROM FEVER BLISTERS and COLD SORES

DRUG FACTS

Active Ingredient

Petrolatum (white) 61%

Lidocaine 0.6%

PURPOSE

Skin Protectant

External or Topical Analgesic

Uses:

TEMPORARY RELIEF OF PAIN AND/OR ITCHING FROM FEVER BLISTERS AND COLD SORES

WARNING:

Keep away from children.

Do not use

if allergic tp any of the ingredients. If condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days then discontinue use of this product and cunsult a doctor.

INGREDIENTS:

   Simmondisa Chinensis (Jojoba) Seed Oil, Lanolin, Beeswax, Ozokerite wax, Candelilla wax, Parafin, Aqua (Water), Polysorbate 60, 2-DG, Ethoxydiglycol, Menthol, Tocopheryl, Cholecalciferal, Retinyl Palmitate, Phytonadione

Package Labeling:

INGREDIENTS AND APPEARANCE

LIPROTEK 
petrolatum, lidocaine ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 67194-017
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U)	PETROLATUM	610 mg  in 1 g
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	6 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
JOJOBA OIL (UNII: 724GKU717M)
LANOLIN (UNII: 7EV65EAW6H)
YELLOW WAX (UNII: 2ZA36H0S2V)
CERESIN (UNII: Q1LS2UJO3A)
CANDELILLA WAX (UNII: WL0328HX19)
PARAFFIN (UNII: I9O0E3H2ZE)
WATER (UNII: 059QF0KO0R)
POLYSORBATE 60 (UNII: CAL22UVI4M)
2-DEOXYGLUCOSE (UNII: 9G2MP84A8W)
DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)
MENTHOL (UNII: L7T10EIP3A)
CHOLECALCIFEROL (UNII: 1C6V77QF41)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
PHYTONADIONE (UNII: A034SE7857)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 67194-017-01	4 g in 1 JAR; Type 0: Not a Combination Product	01/21/2016

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part348	01/21/2016

Labeler - Unit Dose, Ltd. (119080393)